Article Details

GT Biopharma submits IND to FDA for CD33+ leukemia therapy (GTBP) | Seeking Alpha

Retrieved on: 2023-12-04 15:57:55

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma submits IND to FDA for CD33+ leukemia therapy (GTBP) | Seeking Alpha. View article details on HISWAI: https://seekingalpha.com/news/4042938-gt-biopharma-submits-ind-to-fda-for-cd33-leukemia-therapy%3Fsource%3Dcontent_type%253Areact%257Cfirst_level_url%253Amarket-news%257Csection_asset%253Amain

Excerpt

GT Biopharma (GTBP) has submitted an Investigational New Drug application to the FDA for GTB-3650 in the treatment of CD33+ leukemia, ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up